Eagle Boston Investment Management Inc. increased its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 6.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 109,459 shares of the company’s stock after buying an additional 7,011 shares during the period. Eagle Boston Investment Management Inc. owned approximately 0.21% of Nu Skin Enterprises worth $6,878,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Creative Planning increased its stake in shares of Nu Skin Enterprises by 38.5% in the first quarter. Creative Planning now owns 1,800 shares of the company’s stock valued at $100,000 after buying an additional 500 shares in the last quarter. US Bancorp DE increased its stake in shares of Nu Skin Enterprises by 3.3% in the second quarter. US Bancorp DE now owns 2,032 shares of the company’s stock valued at $128,000 after buying an additional 65 shares in the last quarter. TrimTabs Asset Management LLC increased its stake in shares of Nu Skin Enterprises by 88.7% in the first quarter. TrimTabs Asset Management LLC now owns 2,349 shares of the company’s stock valued at $130,000 after buying an additional 1,104 shares in the last quarter. Independent Portfolio Consultants Inc. increased its stake in shares of Nu Skin Enterprises by 1.7% in the first quarter. Independent Portfolio Consultants Inc. now owns 2,375 shares of the company’s stock valued at $132,000 after buying an additional 40 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Nu Skin Enterprises by 23.0% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,506 shares of the company’s stock valued at $139,000 after buying an additional 468 shares in the last quarter. Hedge funds and other institutional investors own 79.25% of the company’s stock.

Shares of Nu Skin Enterprises, Inc. (NYSE NUS) opened at 60.83 on Friday. Nu Skin Enterprises, Inc. has a 52 week low of $46.35 and a 52 week high of $66.04. The stock’s 50 day moving average price is $60.92 and its 200 day moving average price is $57.01. The firm has a market capitalization of $3.22 billion, a P/E ratio of 20.34 and a beta of 1.31.

Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Wednesday, August 2nd. The company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.69 by $0.08. The firm had revenue of $550.10 million for the quarter, compared to the consensus estimate of $548.09 million. Nu Skin Enterprises had a net margin of 7.53% and a return on equity of 24.14%. The business’s quarterly revenue was down 8.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.79 EPS. On average, analysts predict that Nu Skin Enterprises, Inc. will post $3.23 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 13th. Investors of record on Friday, August 25th will be issued a $0.36 dividend. The ex-dividend date is Wednesday, August 23rd. This represents a $1.44 annualized dividend and a yield of 2.37%. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 48.81%.

TRADEMARK VIOLATION NOTICE: This story was first posted by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/eagle-boston-investment-management-inc-buys-7011-shares-of-nu-skin-enterprises-inc-nus/1536061.html.

Several analysts recently issued reports on NUS shares. TheStreet upgraded Nu Skin Enterprises from a “c+” rating to a “b” rating in a report on Wednesday, August 2nd. Pivotal Research reiterated a “buy” rating and issued a $65.00 price target on shares of Nu Skin Enterprises in a report on Thursday, May 4th. BidaskClub downgraded Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Zacks Investment Research upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $70.00 target price for the company in a research note on Wednesday, July 12th. Finally, Deutsche Bank AG raised their target price on Nu Skin Enterprises from $63.00 to $66.00 and gave the company a “buy” rating in a research note on Wednesday, June 21st. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company. Nu Skin Enterprises presently has an average rating of “Hold” and an average target price of $62.88.

In related news, General Counsel D Matthew Dorny sold 8,000 shares of Nu Skin Enterprises stock in a transaction on Monday, June 5th. The shares were sold at an average price of $56.39, for a total value of $451,120.00. Following the transaction, the general counsel now owns 52,730 shares in the company, valued at approximately $2,973,444.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold a total of 31,750 shares of company stock worth $1,946,810 in the last quarter. Insiders own 5.20% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.